Prostatis Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,773
| Closed | -$276K | – | 158 |
|
|
2024
Q4 | $276K | Sell |
2,773
-693
| -20% | -$68.9K | 0.08% | 131 |
|
|
2024
Q3 | $394K | Sell |
3,466
-105
| -3% | -$11.9K | 0.13% | 102 |
|
|
2024
Q2 | $442K | Buy |
3,571
+677
| +23% | +$83.8K | 0.16% | 100 |
|
|
2024
Q1 | $382K | Sell |
2,894
-167
| -5% | -$22K | 0.14% | 103 |
|
|
2023
Q4 | $334K | Sell |
3,061
-296
| -9% | -$32.3K | 0.14% | 101 |
|
|
2023
Q3 | $376K | Sell |
3,357
-172,568
| -98% | -$19.4M | 0.18% | 74 |
|
|
2023
Q2 | $349K | Buy |
175,925
+167,711
| +2,042% | +$333K | 0.16% | 83 |
|
|
2023
Q1 | $891K | Sell |
8,214
-31
| -0.4% | -$3.36K | 0.47% | 52 |
|
|
2022
Q4 | $915K | Buy |
8,245
+5,758
| +232% | +$639K | 0.56% | 45 |
|
|
2022
Q3 | $214K | Buy |
2,487
+125
| +5% | +$10.8K | 0.25% | 60 |
|
|
2022
Q2 | $215K | Buy |
+2,362
| New | +$215K | 0.34% | 42 |
|
|
2020
Q3 | – | Sell |
-4,570
| Closed | -$337K | – | 79 |
|
|
2020
Q2 | $337K | Buy |
+4,570
| New | +$337K | 0.68% | 42 |
|